Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M289Revenue $M61.2Net Margin (%)-160.5Altman Z-Score-39.7
Enterprise Value $M282EPS $-0.6Operating Margin %-147.9Piotroski F-Score3
P/E(ttm)--Beneish M-Score-5.0Pre-tax Margin (%)-162.2Higher ROA y-yN
Price/Book--10-y EBITDA Growth Rate %-45.3Quick Ratio1.8Cash flow > EarningsY
Price/Sales4.35-y EBITDA Growth Rate %-39.0Current Ratio1.9Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-139.2Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-663.1Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M180ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with CTIC

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

CTIC is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


CTIC: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Plunkett MatthewEVP, Corporate Development 2015-08-04Sell10,000$1.84-14.67 view
SINGER JACK WEVP, Global Medical Affairs 2015-07-24Sell15,000$1.91-17.8 view
BIANCO LOUIS AEVP, Finance & Administration 2015-07-23Sell10,000$1.91-17.8 view
Plunkett MatthewEVP, Corporate Development 2015-07-06Sell10,000$1.95-19.49 view
SINGER JACK WEVP, Global Medical Affairs 2015-06-26Sell15,000$2.07-24.15 view
BIANCO LOUIS AEVP, Finance & Administration 2015-06-25Sell10,000$2.18-27.98 view
Plunkett MatthewEVP, Corporate Development 2015-06-04Sell10,000$2.06-23.79 view
SINGER JACK WEVP, Global Medical Affairs 2015-05-22Sell15,000$1.74-9.77 view
BIANCO LOUIS AEVP, Finance & Administration 2015-05-21Sell10,000$1.8-12.78 view
Plunkett MatthewEVP, Corporate Development 2015-05-04Sell10,000$1.86-15.59 view

Quarterly/Annual Reports about CTIC:

    News about CTIC:

    Articles On GuruFocus.com
    Monday Morning Pre-Market Insights: Celldex Therapeutics, Celladon Corp, CTI BioPharma Corp, TG Ther Jun 01 2015 
    Weekly CEO Sells Highlight: Groupon Inc., Cell Therapeutics Inc., Standard Pacific Corp and Dollar G Mar 24 2014 
    These 4 Biotech Stocks Are a Buy Now Feb 08 2012 
    comment on CTIC Dec 16 2011 
    Cell Therapeutics Inc. (CTIC) CEO James A Bianco sells 50,000 Shares Feb 25 2011 
    Cell Therapeutics Inc. (CTIC) CEO James A Bianco sells 50,000 Shares Jan 28 2011 
    Weekly CEO Sells Highlight: CTIC, DDR, UNM, BRCM, TC Jan 09 2011 
    Cell Therapeutics Inc. (CTIC) CEO James A Bianco sells 250,000 Shares Jan 03 2011 
    Cell Therapeutics Inc. (CTIC) CEO James A Bianco sells 200,000 Shares Dec 17 2010 
    Cell Therapeutics Inc. (CTIC) CEO James A Bianco sells 150,000 Shares Dec 10 2010 

    More From Other Websites
    CTI BIOPHARMA CORP Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD... Aug 27 2015
    Falling Earnings Estimates Signal Weakness Ahead for CTI BioPharma (CTIC) Aug 26 2015
    CTI BIOPHARMA CORP Financials Aug 15 2015
    10-Q for CTI BioPharma Corp. Aug 08 2015
    Edited Transcript of CTIC earnings conference call or presentation 6-Aug-15 8:30pm GMT Aug 07 2015
    CTI BioPharma reports 2Q loss Aug 06 2015
    CTI BioPharma reports 2Q loss Aug 06 2015
    CTi Biopharma Corp Earnings Call scheduled for 4:30 pm ET today Aug 06 2015
    CTI BIOPHARMA CORP Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD... Aug 06 2015
    CTI BioPharma Reports Second Quarter 2015 Financial Results Aug 06 2015
    Q2 2015 CTi Biopharma Corp Earnings Release - After Market Close Aug 06 2015
    CTI BIOPHARMA CORP Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD... Jul 30 2015
    CTI BioPharma to Report Second Quarter 2015 Financial Results on August 6, 2015 Jul 28 2015
    CTI BIOPHARMA CORP Files SEC form 8-K, Other Events Jul 27 2015
    CTI BioPharma Appoints Bruce J. Seeley As Executive Vice President and Chief Commercial Officer Jul 27 2015
    CTI BIOPHARMA CORP Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD... Jun 30 2015
    3 Biotech Stocks Under $10 to Trade for Breakouts Jun 18 2015
    Tosedostat In Combination With Low Dose Cytarabine Achieves Primary Endpoint In Phase 2 Study In... Jun 15 2015
    Pacritinib Phase 3 Study Shows Positive Results In Patient Reported Outcomes Measuring Quality Of... Jun 12 2015
    CTI BIOPHARMA CORP Files SEC form 8-K/A, Other Events Jun 11 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK